Hypermetabolism on pediatric positron emission tomography scans of brain glucose metabolism: what does it signify
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
MOTS-c passed 7-5, according to PharmExec
Good Laboratory Practices (GLP): Adhering to GLP principles ensures the quality and integrity of non-clinical laboratory studies
Our team understands the approach to vibrant skin isnt one-size-fits-all, making compounded solutions much more effective
Only use peptides dispensed through a clinical compounding pharmacy